Abstract
In Chapter 20, a general procedure was described for the construction of the intermediate vectors necessary for the insertion of foreign DNA sequences into the vaccinia virus (Vv) genome. The principles and basic methodology for the isolation of recombinant vaccinia viruses will be discussed in this chapter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ensinger, M. J. (1982) Isolation and genetic characterization of temperature-sensitive mutants of vaccinia virus WR. J. Virol 43, 778–790.
Drillien, R., Spehner, D., and Kirn, A. (1982) Complementation and genetic linkage between vaccinia virus temperature-sensitive mutants. Virology 119, 372–381.
Nakano, E., Panicah, D., and Paoletti, E. (1982) Molecular genetics of vaccinia virus Demonstration of marker rescue. Proc. Natl. Acad. Sa. USA 79, 1593–1596.
Condit, R. C, Motyczka, A., and Spizz, G. (1983) Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus. Virology 128, 429–443.
Drillien, R. and Spehner, D. (1983) Physical mapping of vaccinia virus temperaturesensitive mutations. Virology 131, 385–393.
Tartaglia, J. and Paoletti, E. (1985) Physical mapping and DNA sequence analysis of the rifampicin resistance locus in vaccinia virus Virology 147, 394–404.
Baldick, C J. and Moss, B. (1987) Resistance of vaccinia virus to rifampicin conferred by a single nucleotide substitution near the predicted NH2 terminus of a gene encoding an M 62,000 polypeptide. Virology 156, 138–145.
Hruby, D. E. and Ball, L. A. (1982) Mapping and identification of the vaccinia virus thymidine kinase gene. J. Virol. 43, 403–409.
Jones, E. V. and Moss, B. (1984) Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected RNA. J. Virol. 49, 72–77.
Panicali, D. and Paoletti, E. (1982) Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase from herpes simplex virus into the DNA of infectious vaccinia virus. Proc. Natl. Acad Sci. USA 79, 4927–4931.
Mackett, M., Smith, G. I., and Moss, B. (1982) Vaccinia virus, a selectable eukaryotic cloning and expression vector. Proc. Natl. Acad. Sci. USA 79, 7415–7419.
Mackett, M., Smith, G. I., and Moss, B. (1984) General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol 49, 857–864.
Chakrabaru, S., Brechling, K., and Moss, B. (1985) Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5, 3403–3409.
Panicali, D., Grzelecki, A., and Huang, C. (1986) Vaccinia virus vectors utilizing the β-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression. Gene 47, 93–99.
Rhim, J. S., Cho, H. Y, and Huebner, R.J. (1975) Nonproducer human cells induced by murine sarcoma virus. Int. J. Cancer 15, 23–29.
Southern, E. (1975) Detection of specific sequences among DNA fragments seperated by gel electrophoresis. J. Mol. Biol. 98, 503–517.
Joklik, W. K (1962) The preparation and characterization of highly purified radioactively labeled poxvirus. Btochim. Biophys. Acla 61, 292–302.
DeFilippes, F. M. (1976) Restriction enzyme digests of rapidly renaturing fragments of vaccinia virus DNA. J. Virol. 17, 227–238.
Plantrose, D. N., Nishimura, C, and Salzman, N. P. (1962) The purification of vaccinia virus from cell cultures. Virology 18, 294–301.
Franke, C. A., Rice, C. M., Strauss, J. H., and Hruby, D. E. (1985) Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants. Mol. Cell. Biol. 5, 1918–1924.
Bertholet, C, Drillien, R., and Wittek, R. (1985) One hundred base pairs flanking sequence of a vaccinia virus late gene are sufficient to temporarily regulate transcription. Proc. Natl. Acad. Sci. USA 82, 2096–2100.
Franke, C. A. and Hruby, D. E. (1988) Use of the gene encoding neomycin phosphotransferase II to convect linked markers into the vaccinia virus genome Nucleic Acids Res. 16, 1634.
Boyle, D. B. and Coupar, B. E. H. (1988) A dominant selectable marker for the construction of recombinant poxviruses. Gene 65, 123–128.
Falkner, F. G. and Moss, B. (1988) Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors J Virol 62, 1849–1854.
Patel, D. D., Ray, C. A., Drucker, R. P., and Pickup, D. J. (1988) A poxvirus-derived vector that directs high levels of expressed and cloned genes in mammalian cells. Proc. Natl. Acad Sci. USA 9931–9935.
Studier, F. W. and Moffat, B. A. (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol Biol. 189, 113–130.
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83, 8122–8126.
Fuerst, T. R., Earl, P. L., and Moss, B. (1987) Use of a hybrid vaccinia virus T7 RNA polymerase system for expression of target genes. Mol. Cell. Biol. 7, 2538–2544.
Fuerst, T. R. and Moss, B. (1989) Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5′ untranslated leader. J. Mol. Biol. 206, 333–348.
Lane, J. M., Ruben, F. L., Neff, J. M., and Millar, J. D. (1969) Complications in smallpox vaccination. 1968. National surveillance in the United States. N. Engl. J. Med. 21, 1201–1208.
Shida, H., Hinuma, Y, Hatanaka, M., Morita, M., Kidokoro, M., Suzuki, K, Maruyama, T., Takahashi-Nishimari, F., Sugimotoo, M., Kitamura, A., Miyazama, T., and Hayami, M. (1988) Effects and virulences of recombinant vaccinia viruses derived form attenuated strains that express the human T-cell leukemia virus type I envelope gene. J. Virol. 62, 4474–4480.
Buller, R. M. L., Smith, G. L., Cremer, K., Notkins, A. L., and Moss, B. (1985) Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317, 813–815
Rodriguez, D., Rodriguez, J. R., Rodriguez J. F., Trauber, D., and Esteban, M. (1989) Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses. Proc. Natl. Acad. Sci. USA 86,1287–1291.
Dallo, S. and Esteban, M. (1987) Isolation and characterization of attenuated mutants of vaccinia virus. Virology 159, 408–422.
Dallo, S., Rodriguez J. F., and Esteban, M. (1987) A14 K envelope protein of vaccinia virus with an important role in virus-host cell interactions is altered during virus persistence and determines the plaque size phenotype of the virus. Virology 159, 423–432.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 The Humana Press Inc., Clifton, NJ
About this protocol
Cite this protocol
Talavera, A., Rodriguez, J.M. (1991). Isolation and Handling of Recombinant Vaccinia Viruses. In: Collins, M.K.L. (eds) Practical Molecular Virology. Methods in Molecular Biology, vol 8. Humana Press. https://doi.org/10.1385/0-89603-191-8:235
Download citation
DOI: https://doi.org/10.1385/0-89603-191-8:235
Publisher Name: Humana Press
Print ISBN: 978-0-89603-191-3
Online ISBN: 978-1-59259-495-5
eBook Packages: Springer Protocols